|
 |
Breast/Gynecologic
Pathology
LMC’s pathologists provide expert interpretation of needle core
and mammatome biopsies as well as fine needle aspirations,
lumpectomies, and mastectomies of the breast. LMC is at the
forefront of cutting edge diagnostic technologies. Therefore, we
perform immunohistochemical prognostic factors, such as Her2/Neu,
on all newly diagnosed breast cancers. These prognostic and
treatment markers enable the breast oncologist to treat the
patient with the most up to date and precise anti-tumor
medications.
LMC pathologists also interpret cervical and endometrial
biopsies enabling the patient’s physician to diagnose cervical and
endometrial cancers as early as possible to optimize treatment
strategies. When diagnosing dysplasia of the cervix we compare the
biopsy to the patient’s previous PAP smear to ensure concordant
results.
|
|
|